ATR’s VTO, or Voluntary Time Off, Program gives each internal ATR employee 5 paid days per year that they can use to work at a charitable organization(s) of their choosing. This week we are focusing on Kamila Sobczyk and her work with the Alzheimer’s Association.
By all accounts, Julianne Moore delivers an impactful performance in the movie Still Alice. So impactful in fact, that ATR employee Kamila Sobczyk was moved to action and spent her VTO helping the Alzheimer’s Association.
Still Alice tells the tragic story of Alice Howland, renowned scholar of linguistics teaching at Columbia University, and her mental decline due to the irreversible effects of early-onset Alzheimer’s. “This movie has a powerful story that is moving and heartbreaking in every way,” said Kamila. “I gained a deep understanding of this debilitating disease and how it affects entire families. I remain moved and inspired to this day.”
Kamila helped out at a recent event in San Jose, CA by preparing marketing materials, doing table set-up, and helping with guest registration. The event, “Reason to Help”, was a fundraising luncheon aimed at supporting families affected by Alzheimer’s. Guests heard compelling first-hand accounts from newly diagnosed individuals who described the positive impact the Alzheimer’s Association has on families and the overall community.
“This is a perfect example of why we offer a VTO Program here at ATR,” said President & CEO Jerry Brenholz. “We want our employees to be able to find causes they are passionate about and use their expertise to help.”
The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer’s care, support and research. They work on a global, national and local level to enhance care and support for all those affected by Alzheimer’s and other dementias. As the largest non-profit funder of Alzheimer’s research, the Association is committed to accelerating progress of new treatments, preventions and ultimately, a cure. Through their partnerships and funded projects, they have been part of every major research advancement over the past 30 years. The Association is also the leading voice for Alzheimer’s disease advocacy, fighting for critical Alzheimer’s research, prevention and care initiatives at the state and federal level.